Tada Y, Yamawaki I, Ueda S, Matsumoto H, Matsuura N, Yasumoto M, Koda A, Hori M
Hanno Research Center, Taiho Pharmaceutical Company, Ltd., 1-27 Misugidai, Hanno, Saitama 357, Japan.
J Med Chem. 1998 Aug 27;41(18):3330-6. doi: 10.1021/jm970285z.
The derivatives of dimethyl-2-(phenylcarbamoyl)ethylsulfonium p-toluenesulfonates were synthesized and evaluated for antiallergic activity. The 2,3-dihydroxyethoxy group was introduced to the phenyl ring from the standpoint of lipophilicity and electronic effects of substituent. The IgE-induced rat passive cutaneous anaphylaxis (PCA) was inhibited by oral administration of several substituted 2-[(4-propoxyphenyl)carbamoyl]ethyldimethylsulfonium p-toluenesulfonate derivatives. Among them (+/-)-2-[N-[4-(3-ethoxy-2-hydroxypropoxy)phenyl]carbamoyl]ethyldimeth ylsulfonium p-toluenesulfonate (1a, IPD-1151T) was found to possess considerable activity in the PCA test, and it was launched as Suplatast tosilate in Japan.
合成了对甲苯磺酸二甲基-2-(苯基氨基甲酰基)乙锍衍生物,并对其抗过敏活性进行了评估。从取代基的亲脂性和电子效应的角度出发,将2,3-二羟基乙氧基引入苯环。口服几种取代的对甲苯磺酸2-[(4-丙氧基苯基)氨基甲酰基]乙基二甲基锍衍生物可抑制IgE诱导的大鼠被动皮肤过敏反应(PCA)。其中,对甲苯磺酸(±)-2-[N-[4-(3-乙氧基-2-羟基丙氧基)苯基]氨基甲酰基]乙基二甲基锍(1a,IPD-1151T)在PCA试验中具有相当的活性,并在日本作为托西酸舒普拉泰上市。